• Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Consensus Rating of "Buy" by Brokerages

    来源: Buzz FX / 28 11月 2024 02:51:10   America/Chicago


    Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Consensus Rating of "Buy" by Brokerages Written by MarketBeat November 28, 2024 Share Link copied to clipboard. Day One Biopharmaceuticals, Inc. ( NASDAQ:DAWN - Get Free Report ) has rece
    Read more...
分享